MSK Kids conducts clinical trials of potentially more effective therapies for rhabdomyosarcoma. Participants have the chance to receive a new treatment early in its development. Some of our clinical trials are evaluating new drugs. Others are assessing existing drugs and drug combinations used in adults with cancer that may be useful in young people with rhabdomyosarcoma.
Your child’s care team will let you know if your child can participate in a clinical trial. The decision to enroll is entirely voluntary. The study team will explain the benefits and risks of the study to you so you can make an informed decision.